A 10-year follow-up of a landmark trial of intensive glucose control in type 2 diabetes has suggested that the clinical benefit was more than durable but rose with the passage of time, researchers reported recently. Related terms:Rury R HolmanRury R Holman OR Rury Holman diabetes